SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3074% below fair value
$2.60−0.21 (-7.62%)
Close on Nov 19, 2026Market cap $25.92MP/E –Yield –
Scynexis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Scynexis's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 6M, up 2.9% from the year before. Over ten years it grew 45.0% a year on average. The highest annual figure on record is 6M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6M | +2.9% |
| FY2024 | Dec 31, 2024 | 6M | +0.3% |
| FY2023 | Dec 31, 2023 | 6M | +13.6% |
| FY2022 | Dec 31, 2022 | 5M | +61.5% |
| FY2021 | Dec 31, 2021 | 3M | +146.1% |
| FY2020 | Dec 31, 2020 | 1M | +91.2% |
| FY2019 | Dec 31, 2019 | 1M | +27.8% |
| FY2018 | Dec 31, 2018 | 1M | +64.1% |
| FY2017 | Dec 31, 2017 | 0M | +40.5% |
| FY2016 | Dec 31, 2016 | 0M | +56.5% |
| FY2015 | Dec 31, 2015 | 0M | +104.9% |
| FY2014 | Dec 31, 2014 | 0M | +1669.1% |
| FY2013 | Dec 31, 2013 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 12M | +90.1% |
| Q1 FY2026 | Mar 31, 2026 | 6M | +3.1% |
| Q4 FY2025 | Dec 31, 2025 | 6M | +4.0% |
| Q3 FY2025 | Sep 30, 2025 | 6M | +2.6% |
| Q2 FY2025 | Jun 30, 2025 | 6M | +2.6% |
| Q1 FY2025 | Mar 31, 2025 | 6M | +1.8% |
| Q4 FY2024 | Dec 31, 2024 | 6M | +7.3% |
| Q3 FY2024 | Sep 30, 2024 | 6M | +1.5% |
| Q2 FY2024 | Jun 30, 2024 | 6M | -2.8% |
| Q1 FY2024 | Mar 31, 2024 | 6M | +1.7% |
| Q4 FY2023 | Dec 31, 2023 | 6M | -4.6% |
| Q3 FY2023 | Sep 30, 2023 | 6M | +0.8% |
| Q2 FY2023 | Jun 30, 2023 | 6M | +15.3% |
| Q1 FY2023 | Mar 31, 2023 | 6M | +43.9% |
| Q4 FY2022 | Dec 31, 2022 | 6M | +79.0% |
| Q3 FY2022 | Sep 30, 2022 | 6M | +71.2% |
| Q2 FY2022 | Jun 30, 2022 | 5M | +63.4% |
| Q1 FY2022 | Mar 31, 2022 | 4M | +25.1% |
| Q4 FY2021 | Dec 31, 2021 | 3M | +188.1% |
| Q3 FY2021 | Sep 30, 2021 | 3M | +107.3% |
| Q2 FY2021 | Jun 30, 2021 | 3M | +164.6% |
| Q1 FY2021 | Mar 31, 2021 | 3M | +172.2% |
| Q4 FY2020 | Dec 31, 2020 | 1M | +39.8% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +99.6% |
| Q2 FY2020 | Jun 30, 2020 | 1M | +87.9% |
| Q1 FY2020 | Mar 31, 2020 | 1M | +97.6% |
| Q4 FY2019 | Dec 31, 2019 | 1M | +37.5% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +42.6% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +13.7% |
| Q1 FY2019 | Mar 31, 2019 | 1M | +46.9% |
| Q4 FY2018 | Dec 31, 2018 | 1M | +67.2% |
| Q3 FY2018 | Sep 30, 2018 | 1M | +73.6% |
| Q2 FY2018 | Jun 30, 2018 | 1M | +81.5% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +31.4% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +18.8% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +15.6% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?